online-advertising-for-some-diabetes-and-weight-loss-drugs-may-mislead-consumers
[bsa_pro_ad_space id=1]

Digital marketing for compounded variations of a well-known category of type 2 diabetes and weight-reduction treatments frequently encompasses methods that provide only incomplete information or may even mislead consumers, a group of investigators from Yale School of Medicine has discovered.